Allowing private equity players to become sponsors of mutual funds may help democratise the industry further and bring in more players, spurring innovation and growth. On Friday, Sebi floated a consultation paper on review of regulatory framework for sponsors of mutual funds. The working group that has drafted the paper noted that PEs with significant […]
Mankind Pharma shares listed at 20.37% premium over IPO price on NSE and BSE amid positive domestic market. The share debuted at Rs 1300 on the stock exchanges, as compared to the issue price of Rs 1080. The scrip touched a high of 22.87% at Rs 1,327 per share. A positive listing was expected as […]